Diarrhea
127 results
1 - 100- Probiotics for the prevention of pediatric antibiotic‐associated diarrhea
- Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children
- Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants: Cochrane systematic review
- Lactose avoidance for young children with acute diarrhoea: Cochrane systematic review
- Interventions for treating collagenous colitis
- Interventions for treating lymphocytic colitis
- Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis
- Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
- Hypnotherapy for treatment of irritable bowel syndrome: Cochrane systematic review
- Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants: Cochrane systematic review
- Strontium ranelate for preventing and treating postmenopausal osteoporosis
- Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
- Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)
- Aminosalicylates for induction of remission or response in Crohn's disease
- Probiotics for treatment of Clostridium difficile-associated colitis in adults: Cochrane systematic review
- Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
- Mycophenolate mofetil for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
- Anti‐pseudomonal beta‐lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta‐lactams
- Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents: Cochrane systematic review
- Interventions for prevention of post‐operative recurrence of Crohn's disease
- Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
- Fish oil for induction of remission in ulcerative colitis
- Tegaserod for the treatment of irritable bowel syndrome and chronic constipation
- Home‐based care for reducing morbidity and mortality in people infected with HIV/AIDS
- Enteral nutritional therapy for induction of remission in Crohn's disease
- Antibiotics for the prevention of acute and chronic suppurative otitis media in children
- Cyclosporine A for induction of remission in severe ulcerative colitis
- Antibiotics for preventing complications in children with measles: Cochrane systematic review
- Zinc supplementation for mental and motor development in children: Cochrane systematic review
- Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease
- Effectiveness of provision of animal‐source foods for supporting optimal growth and development in children 6 to 59 months of age
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression‐free survival in patients with advanced and/or metastatic colorectal cancer
- Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years: Cochrane systematic review
- Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
- Type I interferons for induction of remission in ulcerative colitis
- Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
- Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia
- Endovascular therapy versus medical treatment for spontaneous isolated dissection of the superior mesenteric artery
- Acamprosate for alcohol dependence
- Antibiotics for acute maxillary sinusitis in adults: Cochrane systematic review
- Immunostimulants for preventing respiratory tract infection in children: Cochrane systematic review
- Certolizumab pegol for induction of remission in Crohn's disease
- Interventions for reducing inflammation in familial Mediterranean fever
- Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
- Interventions for hiring, retaining and training district health systems managers in low- and middle-income countries: Cochrane systematic review
- The role of iron in the management of chemotherapy‐induced anemia in cancer patients receiving erythropoiesis‐stimulating agents
- Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
- Short‐term late‐generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
- Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults
- Budesonide for induction of remission in Crohn's disease: Cochrane systematic review
- Low dose naltrexone for induction of remission in Crohn's disease
- Vitamin A for treating measles in children: Cochrane systematic review
- Strategies to increase the ownership and use of insecticide‐treated bednets to prevent malaria
- Leflunomide for the treatment of rheumatoid arthritis
- Adalimumab for induction of remission in Crohn's disease
- Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children
- Coenzyme Q10 for Parkinson's disease: Cochrane systematic review
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Maximal androgen blockade for advanced prostate cancer: Cochrane systematic review
- Methotrexate for maintenance of remission in Crohn's disease: Cochrane systematic review
- Methotrexate for induction of remission in ulcerative colitis
- Antibiotics for induction and maintenance of remission in Crohn's disease
- Rofecoxib for osteoarthritis
- Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
- Methotrexate for maintenance of remission in ulcerative colitis
- Natalizumab for induction of remission in Crohn's disease
- Interventions for orbital lymphangioma
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis